Rankings
▼
Calendar
NAUT Q2 2025 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$339M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$17M
Net Income
-$15M
EPS (Diluted)
$-0.12
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$14M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$213M
Total Liabilities
$32M
Stockholders' Equity
$181M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2M
-$2M
-2.3%
Operating Income
-$17M
-$21M
+17.8%
Net Income
-$15M
-$18M
+16.5%
← FY 2025
All Quarters
Q3 2025 →